These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 12721262)

  • 1. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
    Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
    J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.
    Westphal M; Ram Z; Riddle V; Hilt D; Bortey E;
    Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety evaluation of high-dose BCNU-loaded biodegradable implants in Chinese patients with recurrent malignant gliomas.
    Sai K; Zhong MG; Wang J; Chen YS; Mou YG; Ke C; Zhang XH; Yang QY; Lin FH; Guo CC; Chen ZH; Zeng J; Lv YC; Li X; Gao WC; Chen ZP
    J Neurol Sci; 2014 Aug; 343(1-2):60-5. PubMed ID: 24874252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
    Emerich DF; Winn SR; Bartus RT
    Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
    Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
    Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control.
    Ewend MG; Brem S; Gilbert M; Goodkin R; Penar PL; Varia M; Cush S; Carey LA
    Clin Cancer Res; 2007 Jun; 13(12):3637-41. PubMed ID: 17575228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
    Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.
    Brem H; Mahaley MS; Vick NA; Black KL; Schold SC; Burger PC; Friedman AH; Ciric IS; Eller TW; Cozzens JW
    J Neurosurg; 1991 Mar; 74(3):441-6. PubMed ID: 1993909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging.
    Hammoud DA; Belden CJ; Ho AC; Dal Pan GJ; Herskovits EH; Hilt DC; Brem H; Pomper MG
    AJR Am J Roentgenol; 2003 May; 180(5):1469-75. PubMed ID: 12704070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial.
    Hassenbusch SJ; Nardone EM; Levin VA; Leeds N; Pietronigro D
    Neoplasia; 2003; 5(1):9-16. PubMed ID: 12659665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
    Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
    Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
    Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
    J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
    Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
    Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.
    Kleinberg LR; Weingart J; Burger P; Carson K; Grossman SA; Li K; Olivi A; Wharam MD; Brem H
    Cancer Invest; 2004; 22(1):1-9. PubMed ID: 15069758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter phase I/II study of the BCNU implant (Gliadel(®) Wafer) for Japanese patients with malignant gliomas.
    Aoki T; Nishikawa R; Sugiyama K; Nonoguchi N; Kawabata N; Mishima K; Adachi J; Kurisu K; Yamasaki F; Tominaga T; Kumabe T; Ueki K; Higuchi F; Yamamoto T; Ishikawa E; Takeshima H; Yamashita S; Arita K; Hirano H; Yamada S; Matsutani M;
    Neurol Med Chir (Tokyo); 2014; 54(4):290-301. PubMed ID: 24739422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
    Brem H; Ewend MG; Piantadosi S; Greenhoot J; Burger PC; Sisti M
    J Neurooncol; 1995 Nov; 26(2):111-23. PubMed ID: 8787853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk Factors for Adverse Events after Implantation of BCNU Wafers in High-grade Gliomas].
    Yoshida M; Yamaguchi S; Ishi Y; Endo S; Motegi H; Kobayashi H; Asaoka K; Kamoshima Y; Terasaka S; Houkin K
    No Shinkei Geka; 2015 Jul; 43(7):603-10. PubMed ID: 26136324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk management in the treatment of malignant gliomas with BCNU wafer implants.
    Giese A; Bock HC; Kantelhardt SR; Rohde V
    Cent Eur Neurosurg; 2010 Nov; 71(4):199-206. PubMed ID: 20063259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers.
    Murai S; Ichikawa T; Kurozumi K; Shimazu Y; Oka T; Otani Y; Shimizu T; Date I
    J Clin Neurosci; 2016 Nov; 33():148-153. PubMed ID: 27452129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
    Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.